Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TO-208 Open-Label Pharmacology Study in Pediatric Molluscum Contagiosum
jRCT2031230204Completed
- Sponsor
- Torii Pharmaceutical
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cantharidin in molluscum contagiosum (MC), sponsored by Torii Pharmaceutical. Primary endpoints: Plasma TO-208 concentration at 2 hours after initial application and Plasma TO-208 concentration at 24 hours after initial application. Started Jul 2023; status: completed.
02
Drugs
cantharidin
03
Conditions
molluscum contagiosum (MC)
Beyond the preview
Go deeper on jRCT2031230204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230204.